Loading...
Ursodeoxycholic Acid 300mg Tab
A potent hepatoprotective and bile-acid modulating medication formulated for the intensive management of chronic liver disorders and the non-surgical dissolution of gallstones. NEXTLIFE-300 contains Ursodeoxycholic Acid (UDCA) 300mg, a naturally occurring hydrophilic bile acid that enhances liver function and prevents biliary complications.
A potent hepatoprotective and bile-acid modulating medication formulated for the intensive management of chronic liver disorders and the non-surgical dissolution of gallstones. NEXTLIFE-300 contains Ursodeoxycholic Acid (UDCA) 300mg, a naturally occurring hydrophilic bile acid that enhances liver function and prevents biliary complications.
Ursodeoxycholic Acid 300mg works by displacing and neutralizing toxic, hydrophobic bile acids that can accumulate and cause damage to liver cell membranes. By replacing these harmful acids, it protects hepatocytes from oxidative stress and slows the progression of liver fibrosis.
NEXTLIFE-300 reduces the cholesterol saturation of bile by inhibiting cholesterol synthesis and secretion in the liver. This creates a chemical environment that allows for the gradual dissolution of radiolucent (cholesterol) gallstones and prevents the formation of biliary sludge.
The medication promotes the secretion and flow of bile through the biliary tract. This helps to clear obstructions in the small bile ducts and effectively reduces symptoms of cholestasis, such as jaundice, fatigue, and persistent itching (pruritus).
UDCA exerts an immunomodulatory effect by suppressing the abnormal expression of HLA antigens on the surface of bile duct cells. This action is critical in managing autoimmune-related liver conditions like Primary Biliary Cholangitis (PBC).
Regular administration of the 300mg strength is clinically proven to significantly reduce elevated levels of liver enzymes (ALT, AST, and GGT). This serves as a key indicator of improved liver health and the reduction of active inflammation within the liver tissue.
Beyond its protective role, NEXTLIFE-300 assists in the healthy emulsification and absorption of dietary fats and fat-soluble vitamins. This supports overall metabolic balance and prevents nutritional deficiencies in patients with impaired bile secretion.
Indication Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis (PSC), Dissolution of Radiolucent Gallstones, Non-Alcoholic Steatohepatitis (NASH), Alcoholic Liver Disease, Chronic Hepatitis with Cholestasis.
Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.
Coral Calcium 500mg + Boron 1.5mg+ Folic Acid 400mcg+Calcitriol 0.25 mcg+ Epa 180mg+ Dha 120 mg Tablet
